TY - JOUR AU - Zhan, S. AU - Shapiro, D. N. AU - Helman, L. J. PY - 1994 DA - 1994// TI - Activation of an imprinted allele of the insulin-like growth factor II gene implicated in rhabdomyosarcoma JO - J Clin Invest VL - 94 UR - https://doi.org/10.1172/JCI117344 DO - 10.1172/JCI117344 ID - Zhan1994 ER - TY - JOUR AU - Merlino, G. AU - Helman, L. J. PY - 1999 DA - 1999// TI - Rhabdomyosarcoma--working out the pathways JO - Oncogene VL - 18 UR - https://doi.org/10.1038/sj.onc.1203038 DO - 10.1038/sj.onc.1203038 ID - Merlino1999 ER - TY - JOUR AU - Rikhof, B. AU - de, J. S. AU - Suurmeijer, A. J. AU - Meijer, C. AU - Graaf, W. T. PY - 2009 DA - 2009// TI - The insulin-like growth factor system and sarcomas JO - J Pathol VL - 217 UR - https://doi.org/10.1002/path.2499 DO - 10.1002/path.2499 ID - Rikhof2009 ER - TY - JOUR AU - Giovanni, C. AU - Landuzzi, L. AU - Nicoletti, G. AU - Lollini, P. L. AU - Nanni, P. PY - 2009 DA - 2009// TI - Molecular and cellular biology of rhabdomyosarcoma JO - Future Oncol VL - 5 UR - https://doi.org/10.2217/fon.09.97 DO - 10.2217/fon.09.97 ID - Giovanni2009 ER - TY - JOUR AU - Hahn, H. AU - Wojnowski, L. AU - Specht, K. AU - Kappler, R. AU - Calzada-Wack, J. AU - Potter, D. PY - 2000 DA - 2000// TI - Patched target Igf2 is indispensable for the formation of medulloblastoma and rhabdomyosarcoma JO - J Biol Chem VL - 275 UR - https://doi.org/10.1074/jbc.C000352200 DO - 10.1074/jbc.C000352200 ID - Hahn2000 ER - TY - JOUR AU - Rezvani, G. AU - Lui, J. C. AU - Barnes, K. M. AU - Baron, J. PY - 2012 DA - 2012// TI - A set of imprinted genes required for normal body growth also promotes growth of rhabdomyosarcoma cells JO - Pediatr Res VL - 71 UR - https://doi.org/10.1038/pr.2011.6 DO - 10.1038/pr.2011.6 ID - Rezvani2012 ER - TY - JOUR AU - Martins, A. S. AU - Olmos, D. AU - Missiaglia, E. AU - Shipley, J. PY - 2011 DA - 2011// TI - Targeting the insulin-like growth factor pathway in rhabdomyosarcomas: rationale and future perspectives JO - Sarcoma VL - 2011 UR - https://doi.org/10.1155/2011/209736 DO - 10.1155/2011/209736 ID - Martins2011 ER - TY - JOUR AU - Kalebic, T. AU - Tsokos, M. AU - Helman, L. J. PY - 1994 DA - 1994// TI - In vivo treatment with antibody against IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down-regulates p34cdc2 JO - Cancer Res VL - 54 ID - Kalebic1994 ER - TY - JOUR AU - Giovanni, C. AU - Melani, C. AU - Nanni, P. AU - Landuzzi, L. AU - Nicoletti, G. AU - Frabetti, F. PY - 1995 DA - 1995// TI - Redundancy of autocrine loops in human rhabdomyosarcoma cells: induction of differentiation by suramin JO - Br J Cancer VL - 72 UR - https://doi.org/10.1038/bjc.1995.490 DO - 10.1038/bjc.1995.490 ID - Giovanni1995 ER - TY - JOUR AU - Pappo, A. S. AU - Vassal, G. AU - Crowley, J. J. AU - Bolejack, V. AU - Hogendoorn, P. C. AU - Chugh, R. PY - 2014 DA - 2014// TI - A phase 2 trial of R1507, a monoclonal antibody to the insulin-like growth factor-1 receptor (IGF-1R), in patients with recurrent or refractory rhabdomyosarcoma, osteosarcoma, synovial sarcoma, and other soft tissue sarcomas: results of a sarcoma Alliance for research through collaboration study JO - Cancer VL - 120 UR - https://doi.org/10.1002/cncr.28728 DO - 10.1002/cncr.28728 ID - Pappo2014 ER - TY - JOUR AU - Wan, X. AU - Yeung, C. AU - Heske, C. AU - Mendoza, A. AU - Helman, L. J. PY - 2015 DA - 2015// TI - IGF-1R inhibition activates a YES/SFK bypass resistance pathway: rational basis for co-targeting IGF-1R and yes/SFK kinase in rhabdomyosarcoma JO - Neoplasia VL - 17 UR - https://doi.org/10.1016/j.neo.2015.03.001 DO - 10.1016/j.neo.2015.03.001 ID - Wan2015 ER - TY - JOUR AU - Disis, M. L. AU - Gad, E. AU - Herendeen, D. R. AU - Lai, V. P. AU - Park, K. H. AU - Cecil, D. L. PY - 2013 DA - 2013// TI - A multiantigen vaccine targeting neu, IGFBP-2, and IGF-IR prevents tumor progression in mice with preinvasive breast disease JO - Cancer Prev Res (Phila) VL - 6 UR - https://doi.org/10.1158/1940-6207.CAPR-13-0182 DO - 10.1158/1940-6207.CAPR-13-0182 ID - Disis2013 ER - TY - JOUR AU - Goya, M. AU - Miyamoto, S. AU - Nagai, K. AU - Ohki, Y. AU - Nakamura, K. AU - Shitara, K. PY - 2004 DA - 2004// TI - Growth inhibition of human prostate cancer cells in human adult bone implanted into nonobese diabetic/severe combined immunodeficient mice by a ligand-specific antibody to human insulin-like growth factors JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-0919 DO - 10.1158/0008-5472.CAN-04-0919 ID - Goya2004 ER - TY - JOUR AU - Miyamoto, S. AU - Nakamura, M. AU - Shitara, K. AU - Nakamura, K. AU - Ohki, Y. AU - Ishii, G. PY - 2005 DA - 2005// TI - Blockade of paracrine supply of insulin-like growth factors using neutralizing antibodies suppresses the liver metastasis of human colorectal cancers JO - Clin Cancer Res VL - 11 UR - https://doi.org/10.1158/1078-0432.CCR-04-1701 DO - 10.1158/1078-0432.CCR-04-1701 ID - Miyamoto2005 ER - TY - JOUR AU - Matsunaka, T. AU - Miyamoto, S. AU - Shitara, K. AU - Ochiai, A. AU - Chiba, T. PY - 2010 DA - 2010// TI - Ligand-specific antibodies to insulin-like growth factors suppress intestinal polyp formation in Apc+/− mice JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-09-0524 DO - 10.1158/1535-7163.MCT-09-0524 ID - Matsunaka2010 ER - TY - JOUR AU - Dransfield, D. T. AU - Cohen, E. H. AU - Chang, Q. AU - Sparrow, L. G. AU - Bentley, J. D. AU - Dolezal, O. PY - 2010 DA - 2010// TI - A human monoclonal antibody against insulin-like growth factor-II blocks the growth of human hepatocellular carcinoma cell lines in vitro and in vivo JO - Mol Cancer Ther VL - 9 UR - https://doi.org/10.1158/1535-7163.MCT-09-1134 DO - 10.1158/1535-7163.MCT-09-1134 ID - Dransfield2010 ER - TY - JOUR AU - Huh, W. W. AU - Skapek, S. X. PY - 2010 DA - 2010// TI - Childhood rhabdomyosarcoma: new insight on biology and treatment JO - Curr Oncol Rep VL - 12 UR - https://doi.org/10.1007/s11912-010-0130-3 DO - 10.1007/s11912-010-0130-3 ID - Huh2010 ER - TY - JOUR AU - Nanni, P. AU - Nicoletti, G. AU - Giovanni, C. AU - Landuzzi, L. AU - Carlo, E. AU - Cavallo, F. PY - 2001 DA - 2001// TI - Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice JO - J Exp Med VL - 194 UR - https://doi.org/10.1084/jem.194.9.1195 DO - 10.1084/jem.194.9.1195 ID - Nanni2001 ER - TY - JOUR AU - Nanni, P. AU - Nicoletti, G. AU - Giovanni, C. AU - Croci, S. AU - Astolfi, A. AU - Landuzzi, L. PY - 2003 DA - 2003// TI - Development of rhabdomyosarcoma in HER-2/neu transgenic p53 mutant mice JO - Cancer Res VL - 63 ID - Nanni2003 ER - TY - JOUR AU - Nanni, P. AU - Giovanni, C. AU - Lollini, P. L. AU - Nicoletti, G. AU - Prodi, G. PY - 1983 DA - 1983// TI - TS/a: a new metastasizing cell line from a BALB/c spontaneous mammary adenocarcinoma JO - Clin Exp Metastasis VL - 1 UR - https://doi.org/10.1007/BF00121199 DO - 10.1007/BF00121199 ID - Nanni1983 ER - TY - JOUR AU - Giovanni, C. AU - Nicoletti, G. AU - Quaglino, E. AU - Landuzzi, L. AU - Palladini, A. AU - Ianzano, M. L. PY - 2014 DA - 2014// TI - Vaccines against human HER2 prevent mammary carcinoma in mice transgenic for human HER2 JO - Breast Cancer Res VL - 16 UR - https://doi.org/10.1186/bcr3602 DO - 10.1186/bcr3602 ID - Giovanni2014 ER - TY - JOUR AU - Astolfi, A. AU - Giovanni, C. AU - Landuzzi, L. AU - Nicoletti, G. AU - Ricci, C. AU - Croci, S. PY - 2001 DA - 2001// TI - Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells JO - Gene VL - 274 UR - https://doi.org/10.1016/S0378-1119(01)00619-9 DO - 10.1016/S0378-1119(01)00619-9 ID - Astolfi2001 ER - TY - JOUR AU - Rochester, M. A. AU - Riedemann, J. AU - Hellawell, G. O. AU - Brewster, S. F. AU - Macaulay, V. M. PY - 2005 DA - 2005// TI - Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer JO - Cancer Gene Ther VL - 12 UR - https://doi.org/10.1038/sj.cgt.7700775 DO - 10.1038/sj.cgt.7700775 ID - Rochester2005 ER - TY - JOUR AU - Nanni, P. AU - Nicoletti, G. AU - Palladini, A. AU - Croci, S. AU - Murgo, A. AU - Antognoli, A. PY - 2007 DA - 2007// TI - Antimetastatic activity of a preventive cancer vaccine JO - Cancer Res VL - 67 UR - https://doi.org/10.1158/0008-5472.CAN-07-2499 DO - 10.1158/0008-5472.CAN-07-2499 ID - Nanni2007 ER - TY - JOUR AU - Ianzano, M. L. AU - Croci, S. AU - Nicoletti, G. AU - Palladini, A. AU - Landuzzi, L. AU - Grosso, V. PY - 2014 DA - 2014// TI - Tumor suppressor genes promote rhabdomyosarcoma progression in p53 heterozygous, HER-2/neu transgenic mice JO - Oncotarget VL - 5 UR - https://doi.org/10.18632/oncotarget.1171 DO - 10.18632/oncotarget.1171 ID - Ianzano2014 ER - TY - JOUR AU - Yang, B. AU - Jeang, J. AU - Yang, A. AU - Wu, T. C. AU - Hung, C. F. PY - 2014 DA - 2014// TI - DNA vaccine for cancer immunotherapy JO - Hum Vaccin Immunother VL - 10 UR - https://doi.org/10.4161/21645515.2014.980686 DO - 10.4161/21645515.2014.980686 ID - Yang2014 ER - TY - JOUR AU - Stevenson, F. K. AU - Ottensmeier, C. H. AU - Rice, J. PY - 2010 DA - 2010// TI - DNA vaccines against cancer come of age JO - Curr Opin Immunol VL - 22 UR - https://doi.org/10.1016/j.coi.2010.01.019 DO - 10.1016/j.coi.2010.01.019 ID - Stevenson2010 ER - TY - JOUR AU - Lollini, P. L. AU - Cavallo, F. AU - Nanni, P. AU - Forni, G. PY - 2006 DA - 2006// TI - Vaccines for tumour prevention JO - Nat Rev Cancer VL - 6 UR - https://doi.org/10.1038/nrc1815 DO - 10.1038/nrc1815 ID - Lollini2006 ER - TY - JOUR AU - Cavallo, F. AU - Giovanni, C. AU - Nanni, P. AU - Forni, G. AU - Lollini, P. L. PY - 2011 DA - 2011// TI - 2011: the immune hallmarks of cancer JO - Cancer Immunol Immunother VL - 60 UR - https://doi.org/10.1007/s00262-010-0968-0 DO - 10.1007/s00262-010-0968-0 ID - Cavallo2011 ER - TY - JOUR AU - Smit, M. A. AU - Jaffee, E. M. AU - Lutz, E. R. PY - 2014 DA - 2014// TI - Cancer immunoprevention--the next frontier JO - Cancer Prev Res (Phila) VL - 7 UR - https://doi.org/10.1158/1940-6207.CAPR-14-0178 DO - 10.1158/1940-6207.CAPR-14-0178 ID - Smit2014 ER - TY - JOUR AU - Finn, O. J. PY - 2018 DA - 2018// TI - The dawn of vaccines for cancer prevention JO - Nat Rev Immunol VL - 18 UR - https://doi.org/10.1038/nri.2017.140 DO - 10.1038/nri.2017.140 ID - Finn2018 ER - TY - JOUR AU - Croci, S. AU - Nicoletti, G. AU - Landuzzi, L. AU - Giovanni, C. AU - Astolfi, A. AU - Marini, C. PY - 2004 DA - 2004// TI - Immunological prevention of a multigene cancer syndrome JO - Cancer Res VL - 64 UR - https://doi.org/10.1158/0008-5472.CAN-04-2341 DO - 10.1158/0008-5472.CAN-04-2341 ID - Croci2004 ER - TY - JOUR AU - Giovanni, C. AU - Nicoletti, G. AU - Palladini, A. AU - Croci, S. AU - Landuzzi, L. AU - Antognoli, A. PY - 2009 DA - 2009// TI - A multi-DNA preventive vaccine for p53/Neu-driven cancer syndrome JO - Hum Gene Ther VL - 20 UR - https://doi.org/10.1089/hum.2008.172 DO - 10.1089/hum.2008.172 ID - Giovanni2009 ER - TY - JOUR AU - Palladini, A. AU - Nicoletti, G. AU - Pappalardo, F. AU - Murgo, A. AU - Grosso, V. AU - Stivani, V. PY - 2010 DA - 2010// TI - In silico modeling and in vivo efficacy of cancer-preventive vaccinations JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-10-0701 DO - 10.1158/0008-5472.CAN-10-0701 ID - Palladini2010 ER - TY - JOUR AU - Quaglino, E. AU - Mastini, C. AU - Amici, A. AU - Marchini, C. AU - Iezzi, M. AU - Lanzardo, S. PY - 2010 DA - 2010// TI - A better immune reaction to Erbb-2 tumors is elicited in mice by DNA vaccines encoding rat/human chimeric proteins JO - Cancer Res VL - 70 UR - https://doi.org/10.1158/0008-5472.CAN-09-2548 DO - 10.1158/0008-5472.CAN-09-2548 ID - Quaglino2010 ER - TY - JOUR AU - Geenen, V. PY - 2012 DA - 2012// TI - The appearance of the thymus and the integrated evolution of adaptive immune and neuroendocrine systems JO - Acta Clin Belg VL - 67 UR - https://doi.org/10.2143/ACB.67.3.2062657 DO - 10.2143/ACB.67.3.2062657 ID - Geenen2012 ER - TY - JOUR AU - Denies, S. AU - Cicchelero, L. AU - Polis, I. AU - Sanders, N. N. PY - 2016 DA - 2016// TI - Immunogenicity and safety of xenogeneic vascular endothelial growth factor receptor-2 DNA vaccination in mice and dogs JO - Oncotarget VL - 7 UR - https://doi.org/10.18632/oncotarget.7265 DO - 10.18632/oncotarget.7265 ID - Denies2016 ER -